Table 5.
Twelve-month patient outcomes in the registry
| Cohort-eligible (CE) registry | Not cohort-eligible (NCE) registry | Total registry | |
|---|---|---|---|
| Total patients with 12-month follow-up | 229 | 860 | 1,089 |
| Since last contact, have any of the following events occurred? | |||
| Cardiac catheterization | 0.9% (2/229) | 1.7% (15/860) | 1.6% (17/1,089) |
| Electrophysiologic study | 1.7% (4/229) | 3.4% (29/860) | 3.0% (33/1,089) |
| Radiofrequency ablation | 1.7% (4/229) | 3.0% (26/860) | 2.8% (30/1,089) |
| Cardiac surgery | 0.0% (0/229) | 2.4% (21/860) | 1.9% (21/1,089) |
| Other hospitalization | 4.4% (10/229) | 3.7% (32/860) | 3.9% (42/1,089) |
| Other serious event | 4.4% (10/229) | 4.3% (37/860) | 4.3% (47/1,089) |
| Any of above | 13.1% (30/229)*a | 18.6% (160/860) | 17.4% (190/1,089) |
| None of above | 86.9% (199/229)a | 81.4% (700/860) | 82.6% (899/1,089) |
| Symptoms that the patient is currently experiencing: | |||
| Palpitations | 14.0% (32/229) | 11.6% (100/860) | 12.1% (132/1,089) |
| Sustained rapid heart beat | 6.6% (15/229) | 5.9% (51/860) | 6.1% (66/1,089) |
| Fainting | 0.9% (2/229) | 1.3% (11/860) | 1.2% (13/1,089) |
| Chest pain | 4.4% (10/229) | 5.8% (50/860) | 5.5% (60/1,089) |
| Exercise intolerance | 0.4% (1/229) | 1.7% (15/860) | 1.5% (16/1,089) |
| Shortness of breath | 2.6% (6/229) | 2.9% (25/860) | 2.8% (31/1,089) |
| Other | 2.6% (6/229) | 4.1% (35/860) | 3.8% (41/1,089) |
| Any of above | 31.4% (72/229) | 33.4% (287/860) | 33.0% (359/1,089) |
| None of above | 68.6% (157/229) | 66.6% (573/860) | 67.0% (730/1,089) |
| Is the patient currently taking antiarrhythmic medication? | |||
| Yes | 7.0% (16/229)**a | 16.3% (140/860) | 14.3% (156/1,089) |
Statistical significance at
*
P < .05
**
P < .001
a
CE registry vs NCE registry.